Israel Englander Novartis Ag Put Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $2.8 Million - $3.19 Million	-26,400 Reduced 48.18%	28,400 $3.27 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $749,817 - $869,697	8,100 Added 17.34%	54,800 $5.83 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $3.52 Million - $4.01 Million	37,000 Added 381.44%	46,700 $4.52 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $5.02 Million - $5.52 Million	-54,400 Reduced 84.87%	9,700 $979,000
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $5.93 Million - $6.72 Million	64,100 New	64,100 $6.47 Million

1,433

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $210B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.